Blog

October 7, 2019
infant_blood_transfusion

It takes a rare blood type from a special group of donors to save an infant: It often is type O-negative and cytomegalovirus-negative.

Rare blood, rare donors

O-negative is the blood type that can be transfused to patients of all blood types, yet makes up only 7% of the population.

Cytomegalovirus (CMV) causes mild to no symptoms in healthy people. CMV is common, with over half of adults being exposed to it by age 40. However, its presence can cause health complications for these tiny patients.

Things done for safety

Two methods are used to remove the virus:

September 30, 2019
google_advertising_stemcells_ban

Scientists and organizations developing legitimate stem cell therapies are applauding a change in Google’s advertising policy that will block online ads for unapproved stem cell treatments.

The change prohibits Google advertising for therapies with no scientific basis, as well as ads for treatments based on scientific findings and those in early stages of clinical trials.

GenCure, a subsidiary of BioBridge Global, only works with stem cell researchers seeking approval for therapies through appropriate regulatory authorities, including the U.S. Food and Drug Administration.

September 23, 2019
stem_cell_outer_space_blog

Findings from space-based science on stem cells could aid in the development of cellular therapies, tissue engineering and other areas of regenerative medicine.

The low-gravity condition onboard the U.S. National Laboratory on the International Space Station (ISS) will provide an opportunity for the McGowan Institute for Regenerative Medicine (MIRM) at the University of Pittsburgh to investigate regenerative medicine and its effect on human health in a new way.

September 16, 2019
gencure_dendreon_blog

The U.S. Food and Drug Administration changed the field of cancer treatment in 2010 when it approved the first immunotherapy for patients with advanced-stage prostate cancer.

Manufactured by Dendreon, PROVENGE (sipuleucel-T) became the first therapeutic cancer vaccine of its kind, taking a patient’s immune cells and programming them to target and attack certain prostate cancer cells.

“Dendreon was ahead of its time when they started,” said Rogelio Zamilpa, Director of Cord Blood with GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global. “They were one of the pioneers in what is now referred to as cell therapy wherein you take a patient’s cells, reprogram them outside of the body, and then infuse them back into the patient.”

September 9, 2019
eye_healing_amniotic_membrane

Major advances in the use of amniotic membrane are making it a more ideal procedure in the field of ophthalmology for certain eye diseases and injuries.

The story of grafting and bandage methods in eye surgery reconstruction was featured in the August issue of EyeWorld Magazine.

“Amniotic membrane is a popular choice among ophthalmologists for many different types of ocular reconstruction surgeries pertaining to the anterior segment of the eye,” said Jennifer Wehmeyer, Scientist II, Research & Development at BioBridge Global.

Amniotic membrane, or amnion, is the innermost layer of the placenta that forms around the fetus. The amnion is carefully removed from the rest of the placenta, cleaned and sterilized, and then preserved for transplant through freezing or dehydration.

Pages